Seaport Diagnostics
PrivateLast Round
Series B
Jul 12, 2018
Total Funding Raised
$50M
Company Overview
Seaport Diagnostics is a biotechnology company that develops molecular diagnostic testing and consumer-focused genetic testing kits.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, D2C Brands, Sports & Fitness
Business Model
B2C
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Seaport Diagnostics Comparables
Compare Seaport Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SelfDecode | 76% | |
| Everly Health | 76% | |
| LetsGetChecked | 73% |
Seaport Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 12, 2018 | ||||
| Series A Extension | Jun 27, 2017 | ||||
| Series A | Dec 16, 2015 | ||||
| Seed | Feb 5, 2015 |
Seaport Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Haitong International Securities Group | Series B |
| Vectr Ventures | Series B |
| Spectrum Health Ventures | Series B, Series A Extension |
| MMIC Investment Holdings, Inc. | Series B |
| Hatteras Venture Partners | Series B, Seed, Series A, Series A Extension |
| KTB Ventures | Seed, Series B |
| Alexandria Venture Investments | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 27, 2017
$20M round led by Hatteras Venture Partners.
- Dec 16, 2015
$13M round led by Hatteras Venture Partners and Syno Capital.
Seaport Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Seaport Diagnostics's valuation, stock price, and market status.
Is Seaport Diagnostics a public or private company?
Seaport Diagnostics is a private company.
What is the current stock price of Seaport Diagnostics?
Seaport Diagnostics is a private company with no public stock price. No recent secondary market data is available.
How much is Seaport Diagnostics worth (valuation)?
Valuation information for Seaport Diagnostics is not publicly available.
Can I buy Seaport Diagnostics stock?
Seaport Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Seaport Diagnostics's last funding round?
Seaport Diagnostics's most recent funding round was Series B on July 11, 2018.
Who are the main investors in Seaport Diagnostics?
Key investors in Seaport Diagnostics include Hatteras Venture Partners, Syno Capital.
Will Seaport Diagnostics IPO soon?
No public IPO plans have been announced for Seaport Diagnostics.
How can I track Seaport Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Seaport Diagnostics's secondary market activity and sign up for updates.